These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 11932478)
1. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality? Chau I; Cunningham D N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478 [No Abstract] [Full Text] [Related]
2. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626 [TBL] [Abstract][Full Text] [Related]
3. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062 [TBL] [Abstract][Full Text] [Related]
6. [Colorectal cancer and inhibition of cyclooxygenase-2]. Geissler M; Mohr L; Blum HE Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285 [No Abstract] [Full Text] [Related]
7. Sulindac in familial adenomatous polyposis. Levy R N Engl J Med; 2002 Aug; 347(8):615. PubMed ID: 12192027 [No Abstract] [Full Text] [Related]
8. Aspirin use and potential mechanisms for colorectal cancer prevention. Williams CS; Smalley W; DuBois RN J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096 [No Abstract] [Full Text] [Related]
9. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer. Evans JF Am J Clin Oncol; 2003 Aug; 26(4):S62-5. PubMed ID: 12902858 [TBL] [Abstract][Full Text] [Related]
10. [The transgenic mouse model of familial polyposis coli]. Fehmann HC; Eissele R Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555 [No Abstract] [Full Text] [Related]
12. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063 [TBL] [Abstract][Full Text] [Related]
13. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective]. MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824 [No Abstract] [Full Text] [Related]
14. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache]. MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443 [No Abstract] [Full Text] [Related]
15. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?]. Hinz B; Brune K MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088 [No Abstract] [Full Text] [Related]
16. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]
17. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA; Patrono C N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
19. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain]. Nasonova VA Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752 [No Abstract] [Full Text] [Related]
20. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case. Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]